The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pbio.3001554
PubMed Identifier: 36026478
Publication URI: http://europepmc.org/abstract/MED/36026478
Type: Journal Article/Review
Parent Publication: PLOS Biology
Issue: 8
ISSN: 1544-9173